MERCK Kommanditgesellschaft auf Aktien

PINK:MKGAF USA Drug Manufacturers - Specialty & Generic
Market Cap
$16.21 Billion
Market Cap Rank
#1166 Global
#897 in USA
Share Price
$125.45
Change (1 day)
-11.54%
52-Week Range
$125.45 - $144.43
All Time High
$252.52
About

Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables,… Read more

MERCK Kommanditgesellschaft auf Aktien (MKGAF) - Total Assets

Latest total assets as of September 2025: $59.76 Billion USD

Based on the latest financial reports, MERCK Kommanditgesellschaft auf Aktien (MKGAF) holds total assets worth $59.76 Billion USD as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

MERCK Kommanditgesellschaft auf Aktien - Total Assets Trend (2002–2024)

This chart illustrates how MERCK Kommanditgesellschaft auf Aktien’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

MERCK Kommanditgesellschaft auf Aktien - Asset Composition Analysis

Current Asset Composition (December 2024)

MERCK Kommanditgesellschaft auf Aktien's total assets of $59.76 Billion consist of 26.1% current assets and 73.9% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 4.2%
Accounts Receivable $4.08 Billion 7.9%
Inventory $4.48 Billion 8.7%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $6.28 Billion 12.2%
Goodwill $19.15 Billion 37.1%

Asset Composition Trend (2002–2024)

This chart illustrates how MERCK Kommanditgesellschaft auf Aktien's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: MERCK Kommanditgesellschaft auf Aktien's current assets represent 26.1% of total assets in 2024, a decrease from 41.9% in 2002.
  • Cash Position: Cash and equivalents constituted 4.2% of total assets in 2024, down from 4.5% in 2002.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 49.0% of total assets, an increase from 24.0% in 2002.
  • Asset Diversification: The largest asset category is goodwill at 37.1% of total assets.

MERCK Kommanditgesellschaft auf Aktien Competitors by Total Assets

Key competitors of MERCK Kommanditgesellschaft auf Aktien based on total assets are shown below.

Company Country Total Assets
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
USA $67.26 Billion
Kamada
NASDAQ:KMDA
USA $378.79 Million
One World Pharma Inc
OTCQB:OWPC
USA $6.62 Million
Dongwha Pharm.Co.Ltd
KO:000020
Korea ₩654.63 Billion
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
China CN¥27.28 Billion
Yuhan Corp.
KO:000100
Korea ₩3.05 Trillion
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
China CN¥4.97 Billion
Kotra Industries Bhd
KLSE:0002
Malaysia RM363.90 Million

MERCK Kommanditgesellschaft auf Aktien - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.34 - 0.46

Moderate asset utilization - MERCK Kommanditgesellschaft auf Aktien generates 0.41x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: 2.93% - 9.15%

Solid ROA - For every $100 in assets, MERCK Kommanditgesellschaft auf Aktien generates $5.39 in net profit.

MERCK Kommanditgesellschaft auf Aktien - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.49 1.33 1.01
Quick Ratio 1.05 0.91 0.65
Cash Ratio 0.00 0.00 0.00
Working Capital $4.97 Billion $ 3.47 Billion $ 49.00 Million

MERCK Kommanditgesellschaft auf Aktien - Advanced Valuation Insights

This section examines the relationship between MERCK Kommanditgesellschaft auf Aktien's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 1.91
Latest Market Cap to Assets Ratio 0.32
Asset Growth Rate (YoY) 6.3%
Total Assets $51.57 Billion
Market Capitalization $16.25 Billion USD

Valuation Analysis

Below Book Valuation: The market values MERCK Kommanditgesellschaft auf Aktien's assets below their book value (0.32 x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: MERCK Kommanditgesellschaft auf Aktien's assets grew by 6.3% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for MERCK Kommanditgesellschaft auf Aktien (2002–2024)

The table below shows the annual total assets of MERCK Kommanditgesellschaft auf Aktien from 2002 to 2024.

Year Total Assets Change
2024-12-31 $51.57 Billion +6.33%
2023-12-31 $48.49 Billion -0.06%
2022-12-31 $48.53 Billion +6.98%
2021-12-31 $45.36 Billion +8.53%
2020-12-31 $41.80 Billion -4.60%
2019-12-31 $43.81 Billion +18.77%
2018-12-31 $36.89 Billion +3.56%
2017-12-31 $35.62 Billion -6.88%
2016-12-31 $38.25 Billion +0.64%
2015-12-31 $38.01 Billion +46.12%
2014-12-31 $26.01 Billion +24.94%
2013-12-31 $20.82 Billion -3.81%
2012-12-31 $21.64 Billion -2.16%
2011-12-31 $22.12 Billion -1.20%
2010-12-31 $22.39 Billion +33.96%
2009-12-31 $16.71 Billion +6.83%
2008-12-31 $15.64 Billion +4.84%
2007-12-31 $14.92 Billion +84.17%
2006-12-31 $8.10 Billion +11.29%
2005-12-31 $7.28 Billion +27.24%
2004-12-31 $5.72 Billion -18.05%
2003-12-31 $6.98 Billion -7.04%
2002-12-31 $7.51 Billion --